Dragonfly Therapeutics' Unattributed Round

Dragonfly Therapeutics raised a round of funding on May 15, 2017.

Dragonfly Therapeutics is a discovery-stage company developing drugs to stimulate immune responses against cancer. The company is developing novel first-in-class therapeutics targeted at natural kille…

Articles about Dragonfly Therapeutics' Unattributed Round: